Results 11 to 20 of about 43,829 (215)

Study of the teratogenicity of the vaccine strain of the Rubella virus «Orlov-V» (Matonaviridae: Rubivirus: Rubella virus) in experience on rhesus macaques

Вопросы вирусологии, 2021
Introduction. Rubella virus has pronounced teratogenic properties that can cause generalized and persistent intrauterine infection of the fetus. As a result, the control of the loss of teratogenicity inherent in «wild-type» virus strains is a necessary ...
I. N. Lavrentjeva, O. A. Shamsutdinova, I. I. Chugueva, D. D. Karal-ogly, O. I. Vyshemirskiy   +4 more
doaj   +1 more source

Measles among healthcare workers in Italy. Is it time to act? [PDF]

, 2020
Vaccination of healthcare workers (HCWs) against measles is strongly recommended in Europe. In this study, we examined the impact of measles on Italian HCWs by systematically and quantitatively analyzing measles cases involving HCWs over time and by ...
Adamo, G., Baccolini, V., Bella, A., De Vito, C., Filia, A., Magurano, F., Marzuillo, C., Massimi, A., Rosso, A., Sindoni, A., Villari, P.   +10 more
core   +2 more sources

The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015

Vaccines, 2022
Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years.
Ravit Bassal, Tamy Shohat, Tal Levin, Rakefet Pando, Eilat Shinar, Doron Amichay, Mira Barak, Anat Ben-Dor, Adina Bar-Haim, Ella Mendelson, Dani Cohen, Lital Keinan-Boker, Victoria Indenbaum   +12 more
doaj   +1 more source

Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries

Papillomavirus Research, 2019
Rubella vaccine was not part of national immunization programs (NIP) in several countries in the Middle East and North Africa (MENA), South-East Asia (SEA), and South Africa regions until the year 2000.
Asmaa Gohar, Nourtan F. Abdeltawab, Nahla Shehata, Magdy A. Amin   +3 more
doaj   +1 more source

Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models [PDF]

, 2009
We evaluated the effectiveness of a measles vaccine campaign in rural Kenya, based on oral-fluid surveys and mixture-modelling analysis. Specimens were collected from 886 children aged 9 months to 14 years pre-campaign and from a comparison sample of 598
E. O. OHUMA, E. A. OKIRO, A. BETT, J. ABWAO, S. WERE, D. SAMUEL, A. VYSE, N. GAY, D. W. G. BROWN, D. J. NOKES, Nokes, Vyse, Kremer, Enquselassie   +13 more
core   +1 more source

Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda

BMC Infectious Diseases, 2020
Background Control of Rubella and Congenital Rubella Syndrome using vaccination has shown great success in the America’s. Uganda is due to introduce the Rubella vaccine however the magnitude of transmission is not well documented.
Fred Bagenda, Edgar Mugema Mulogo, Richard Onyuthi Apecu, Anette Kisakye, Benard Toliva Opar   +4 more
doaj   +1 more source

Biological properties of domestic strain vRub-Ant of rubella virus

Журнал микробиологии, эпидемиологии и иммунобиологии, 2022
Introduction. Rubella is a mild infectious disease affecting mainly children and is caused by the rubella virus, part of the Matonoviridae family, genus Rubivirus.
Firaya G. Nagieva, Elena P. Barkova, Alexandra D. Stroeva, Yulia I. Ammur, Alexander V. Sidorov, Olga S. Kharchenko, Georgy N. Bukhtoyarov, Oksana A. Svitich, Vitaly V. Zverev   +8 more
doaj   +1 more source

Measles in Italy: Viral strains and crossing borders. [PDF]

, 2019
In 2017, Italy experienced one of the largest outbreaks of measles in recent years, with 5404 notified cases and 4347 confirmed cases. A further 2029 cases were notified during the first 6 months of 2018, and 1516 of them were laboratory-confirmed.
Baggieri M, Bucci P, Magurano F, Marchi A, Mazzilli F, Nicoletti L, Tramuto F   +6 more
core   +1 more source

Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.

PLoS ONE, 2022
The Democratic Republic of the Congo (DRC) has a high measles incidence despite elimination efforts and has yet to introduce rubella vaccine. We evaluated the performance of a prototype rapid digital microfluidics powered (DMF) enzyme-linked immunoassay (
Alaine K Knipes, Aimee Summers, Alexandros A Sklavounos, Julian Lamanna, Richard P S de Campos, Tanya Narahari, Christopher Dixon, Ryan Fobel, Yassa D Ndjakani, Leopold Lubula, Alain Magazani, Jean Jacques Muyembe, Yvonne Lay, Elizabeth Pukuta, Diane Waku-Kouomou, Lijuan Hao, Jolie Kasongo Kayembe, Christian Fobel, Joshua Dahmer, Adam Lee, Man Ho, Jose Gilberto Camacho Valenzuela, Darius G Rackus, Roger Shih, Brendon Seale, Ann Chang, Gilson Paluku, Paul A Rota, Aaron R Wheeler, Heather M Scobie   +29 more
doaj   +1 more source

The reform of the Italian legislation on childhood immunization [PDF]

, 2018
Upon the proposal of the Italian government, Law n. 191/2017 has been enacted, meant to considerably raise the number of mandatory vaccinations, while leaving several others merely "recommended" (non-mandatory).
Cocchiara, Rosario Andrea, La Torre, Giuseppe, Marinelli, Enrico, Montanari Vergallo, Gianluca, Zaami, Simona   +4 more
core   +1 more source